"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
NYS Entity Status
NYS Filing Date
DECEMBER 10, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - BELMONT SALES & MARKETING INC.
Around the Web
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
- Time Inc Taps Schraft To Head Foundry's Content Sales, 'New Yorker' Hires First Newsletter Director
Thursday Jul 13, 2017
In a move to expand its native advertising business, Time Inc. has promoted Chris Schraft to president of content sales and agency development of The Foundry, its branded content studio. 'The NewYorker' has hired Dan Oshinsky as its first director of newsletters.
- Shot-tracking systems churn out valuable data for golfers, manufacturers
By David Dusek - Tuesday Oct 17, 2017
On the Tuesday before the Presidents Cup at the posh Fenway Golf Club in Scarsdale, N.Y., TaylorMade announced it has partnered with Samsung (...)
- Abbvie’s hep C drug pricing threatens Gilead’s dominance
By Max Nisen - Tuesday Aug 8, 2017
Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.
- Yahoo Completes Sale Of Business To Verizon
Tuesday Jun 13, 2017
Yahoo on Tuesday said it completed the sale of its operating media business to Verizon Communications for approximately $4.48 billion. As previously announced, on June 16, 2017, the remaining part ofYahoo will change its name to Altaba Inc. Verizon will combine Yahoo with AOL properties to create Oath.